Dare Bioscience, Inc. (DARE) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of a loss of $0.57 per share. This compares to loss of $1.20 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 366.67%. A quarter ago, it was expected that this company would post a loss of $0.72 per share when it actually produced a loss of $0.84, delivering a surprise of -16.67%. Over the last four quarters, ...